atrial fibrillation heart arrythmia
Conditions
Interventions
Every patient receives a satisfaction questionnaire at the beginning and the
end of the study.
In addition, patients randomised to the WIPPS arm have to complete an
e-learning on atrial fibrillatio
Sponsors
stichting Begeleide Zelfzorg
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: - Age18 and above - Patients diagnosed with atrial fibrillation who have a CHADS2-score of 2 or higher, or CHADS-2VASc-score of 1 or higher - Patients must be able to communicate with the nurse or physician through the web-based system. - Patients must have a medical indiaction as endorsed by the treating medical specialist to switch to or start with Rivaroxaban
Exclusion criteria
Exclusion criteria: - Younger than 18 years of age - Not fluent in Dutch - Pregnancy - Life expectancy less than one year - Reduced cognitive capacity - Most recent creatinin clearance (24 hour creatinin clearance) less than 30 ml/min - NYHA class III of IV heart failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome is the percentage of compliant patients. Compliance of individual patients is usually reported as the percentage of the prescribed doses of the medication actually taken by the patient over a specified period Compliance in the trial will be measured by The Medication Possession Rate (MPR). The MPR is calculated by dividing the number of days for which medication has been suplied by the number of days between refills at the pharmacist. As patients can pick up medication before they run out, compliance can be over 100%. A patient is considered compliant or adherent when MPR = 80% - 120%. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. This will be measured, using a custom-made questionnaire, regarding aspects of care tailored to patients using anticoagulant medication. | — |
Countries
Netherlands
Outcome results
None listed